Home › Funds › OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC › CVS

OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC position in CVS

CVS HEALTH CORP · Consumer Staples

OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC reported holding 119,356 shares of CVS (CVS HEALTH CORP) in its Q2 2026 13F filing — a position valued at US$12.3M, representing 0.69% of its reported portfolio and ranking #46 among its reported holdings. OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC has disclosed CVS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)119.36K sh
Reported value held$12.35M
Portfolio Weight0.69%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC's CVS position evolved

OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC first disclosed a stake in CVS in Q3 2023 at 149,202 shares (US$10.4M). The position peaked in Q1 2025 at 195,354 shares, worth US$13.2M. Across 12 filings, OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 119,356 shares valued at US$12.3M — a reduction of -5,136 shares quarter over quarter.. Notable position changes include a 32% increase in Q2 2024 (shares rose 8% over the following quarter), a 38% trim in Q2 2025 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 149.20K $10.42M New
Q4 2023 153.64K $12.13M Add
Q1 2024 159.49K $12.72M Add
Q2 2024 211.00K $12.46M Add
Q3 2024 209.12K $13.15M Reduce
Q4 2024 206.81K $9.28M Reduce
Q1 2025 195.35K $13.24M Reduce
Q2 2025 120.66K $8.32M Reduce
Q3 2025 122.50K $9.24M Add
Q4 2025 119.86K $9.51M Reduce
Q1 2026 124.49K $8.94M Add
Q2 2026 119.36K $12.35M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CVS and 13F data

CVS (CVS HEALTH CORP) is a Consumer Staples company. 39 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$7.75B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CVS

All CVS fund holders →

FAQ

How long has OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC held CVS?

OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC has disclosed CVS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC's current position in CVS?

As of Q2 2026, OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC holds 119.36K shares of CVS (CVS HEALTH CORP), valued at $12.35M, representing 0.69% of its reported portfolio and ranking #46.

Has OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC been buying or selling CVS?

In the latest 13F filing (Q2 2026), OSBORNE PARTNERS CAPITAL MANAGEMENT, LLC reduced its position in CVS. The position peaked in Q1 2025 at 195.35K shares.

Which other funds hold CVS?

Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.